€
6.85
Nov 29
Business Description
AS Latvijas Juras medicinas centrs
ISIN : LV0000100741
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.68 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.55 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | 6.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.25 | |||||
9-Day RSI | 37.34 | |||||
14-Day RSI | 44.68 | |||||
6-1 Month Momentum % | -12.5 | |||||
12-1 Month Momentum % | -26.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.8 | |||||
Cash Ratio | 0.53 | |||||
Days Inventory | 6.23 | |||||
Days Sales Outstanding | 3.23 | |||||
Days Payable | 18.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.46 | |||||
3-Year Dividend Growth Rate | -43.3 | |||||
5-Year Yield-on-Cost % | 0.54 | |||||
Shareholder Yield % | 1.44 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 2.38 | |||||
Operating Margin % | -3.31 | |||||
Net Margin % | -1.48 | |||||
FCF Margin % | 0.42 | |||||
ROE % | -2.34 | |||||
ROA % | -1.63 | |||||
ROIC % | -3.76 | |||||
ROC (Joel Greenblatt) % | -4.24 | |||||
ROCE % | -4.49 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 15.38 | |||||
PS Ratio | 0.54 | |||||
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 0.89 | |||||
Price-to-Free-Cash-Flow | 129.25 | |||||
Price-to-Operating-Cash-Flow | 12.69 | |||||
EV-to-EBIT | -13.81 | |||||
EV-to-EBITDA | -13.81 | |||||
EV-to-Revenue | 0.46 | |||||
EV-to-FCF | 108.21 | |||||
Price-to-Projected-FCF | 1.24 | |||||
Price-to-Median-PS-Value | 0.82 | |||||
Earnings Yield (Greenblatt) % | -7.24 | |||||
FCF Yield % | 0.78 | |||||
Forward Rate of Return (Yacktman) % | 18.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AS Latvijas Juras medicinas centrs Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 10.183 | ||
EPS (TTM) (€) | -0.199 | ||
Beta | 0 | ||
Volatility % | 61.24 | ||
14-Day RSI | 44.68 | ||
14-Day ATR (€) | 0.067128 | ||
20-Day SMA (€) | 6.91 | ||
12-1 Month Momentum % | -26.7 | ||
52-Week Range (€) | 5.7 - 10.1 | ||
Shares Outstanding (Mil) | 0.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AS Latvijas Juras medicinas centrs Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AS Latvijas Juras medicinas centrs Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
AS Latvijas Juras medicinas centrs Frequently Asked Questions
What is AS Latvijas Juras medicinas centrs(ORSE:LJM1R)'s stock price today?
When is next earnings date of AS Latvijas Juras medicinas centrs(ORSE:LJM1R)?
Does AS Latvijas Juras medicinas centrs(ORSE:LJM1R) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |